Matched Signals
No stored keyword or signal matches were recorded for this activity window.
Correspondence Activity Detail
FibroBiologics, Inc. (FBLG)
Activity window: Sep. 29, 2025 to Sep. 28, 2026
Filings In This Window
| Date | Form | Sentiment | Urgency | Summary | Open |
|---|---|---|---|---|---|
| Mar. 27, 2026 | CORRESP | Neutral/Informational | Moderate | FibroBiologics, Inc. has submitted a request to accelerate the effective date of its registration statement on Form S-1 to March 31, 2026. H.C. Wainwright & Co., LLC, acting as th… | Read Filing EDGAR |
| Mar. 27, 2026 | CORRESP | Neutral/Informational | Moderate | FibroBiologics, Inc. has submitted a request to the SEC to accelerate the effective date of their Registration Statement on Form S-1. They are seeking to have the registration eff… | Read Filing EDGAR |
| Mar. 24, 2026 | UPLOAD | Neutral/Informational | Low | The SEC correspondence informs FibroBiologics, Inc. that they do not intend to review the company's draft registration statement submitted on March 20, 2026. The SEC requests that… | Read Filing EDGAR |
| Dec. 29, 2025 | UPLOAD | Neutral/Informational | Low | The SEC has communicated to FibroBiologics, Inc. that they will not review the company's registration statement filed on December 23, 2025. This decision emphasizes that the respo… | Read Filing EDGAR |
| Dec. 29, 2025 | CORRESP | Neutral/Informational | Moderate | FibroBiologics, Inc. has submitted a request to the SEC to accelerate the effective date of their Registration Statement on Form S-1. They are seeking for the effective date to be… | Read Filing EDGAR |
Notable 8-Ks In This Window
No notable 8-Ks were stored for this company in this activity window.